| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |